NBRV News and Press, Nabriva Therapeutics plc From 08/05/21

Acurx Pharmaceuticals Joins the Antimicrobials Working Group PR Newswire WASHINGTON , Aug. 5, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (Acurx) to its coalition of c...

DUBLIN, Ireland, July 22, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will report its second quarter fi...

Nabriva Therapeutics plc (NASDAQ:NBRV) traded today at a new 52-week low of $1.10. Approximately 12.1 million shares have changed hands today, as compared to an average 30-day volume of 1.8 million shares. In the past 52 weeks, shares of Nabriva Therapeutics plc have traded between the c...

Nabriva Therapeutics plc (NASDAQ:NBRV) traded at a new 52-week low today of $1.13. So far today approximately 12.1 million shares have been exchanged, as compared to an average 30-day volume of 7.4 million shares. Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Na...

Nabriva Therapeutics plc (NASDAQ:NBRV) traded today at a new 52-week low of $1.20. Approximately 12.1 million shares have changed hands today, as compared to an average 30-day volume of 7.3 million shares. Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is...

Nabriva Therapeutics plc (NASDAQ:NBRV) traded at a new 52-week low today of $1.25. This new low was reached on above average trading volume as 12.1 million shares traded hands, while the average 30-day volume is approximately 7.3 million shares. There is potential upside of 82.5% for sha...

Nabriva Therapeutics plc (NASDAQ:NBRV) traded at a new 52-week low today of $1.28. Approximately 12.1 million shares have changed hands today, as compared to an average 30-day volume of 7.1 million shares. Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is...

Crestone Joins Antimicrobials Working Group PR Newswire WASHINGTON , June 8, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. (Crestone) to its coalition of companies with the mission to combat drug r...

- Principal Repayments Delayed At Least Until January 1, 2022 - Repayment Delay and Recent ATM Activity Extends Cash Runway Substantially Through the First Quarter of 2022 DUBLIN, Ireland and FORT WASHINGTON, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc ...

DUBLIN, Ireland and FORT WASHINGTON, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced today that Dr. Ma...